FREE for AMAPP Members (you can access your discount code in the Slack channel under #webinars)

Non-Members can join us for $15 +BF

Learn how to:

Leverage Ketamine's Therapeutic Potential: Understand the science, delivery methods, and integration with psychotherapy.
Navigate the Regulatory Landscape: Ensure compliance and patient safety.
Set Up Your Clinic: Develop treatment protocols, implement clinical governance, and learn from real-world case studies

About Dr Lewis:

Dr Llew Lewis completed his medical training in South Africa at the University of Witwatersrand in 1994. He did his internship at Baragwanath Hospital in Soweto and specialised in Psychiatry, becoming a Fellow of the College of Psychiatrists (South Africa) in 2000. He undertook further training in the London Deanery, achieving his Certificate of Completion of Specialist Training (CCST) IN 2006 and completing a Postgraduate Diploma in CBT at the Royal Holloway University (London) in the UK. He was appointed as a Consultant Psychiatrist in 2006 with South Essex Partnership Foundation University Trust (SEPT).

Dr Lewis has interests in new service development and has led transformation of service model changes in in-patient and community settings, establishing the functional model of New Ways of Working, developing Lithium, Depot and Wellbeing Specialist Clinics, establishing a DBT service and consultation liaison services in two District General Hospitals. Since 2010 he led the development of a ‘Maintaining Adherence Programme’ in SEPT, based on the pioneering work of Dr Werner Kissling of Munich, Germany, in a joint partnership relationship with Janssen-Cilag.

The Maintaining Adherence Programme, developed by Dr Lewis, won the Patient Experience Network National Award in the category of Providing Information to Patients and Carers in 2013.The work was short listed for the Nursing Times awards 2014, highly commended in the Positive Practice in Mental Health Awards 2014 and won the Royal College of Psychiatrists Adult Psychiatric Team of the Year Awards 2014.

Dr Lewis has pursued a career in medical management, commencing in December 2009 as Clinical Director for Inpatients, Addictions, Psychotherapies and Rehabilitation Psychiatry, followed by the appointment as Deputy Medical Director, Essex, in November 2011. From 2011- 2013 he was the Chair of the Physical and Mental health workstream of the Managed Clinical Network in the East of England. From 2012-2013 he was the Chair of the East of England Psychiatric Specialities Advisory Group. (ERPSAG).

Dr Lewis moved to Australia and was appointed as Clinical Director for Community Mental Health at ACT Health and Canberra Health Services in 2017 where he led the implementation of a contemporary community mental health model of care, including establishing Assertive Community Outreach Services and the Home Assessment and Acute Response Team. He achieved his Fellowship of the Royal Australian and New Zealand College of Psychiatrists in 2018. He served as Director of Clinical Services in the Mental Health Division of Canberra Hospital Services from 2020 until 2021 leading the development of the Coronavirus Pandemic Plan for the Division of Mental Health Justice Health ad Alcohol and Drug Services.

He is presently the Senior Specialist in the mental health crisis service in Canberra and is actively participating in registrar education and training and is the medical lead of a randomised controlled trial in physical and dietary interventions in patients on antipsychotics. Dr Lewis is an Honorary Clinical Fellow at the Australian National University and Principal Investigator in a randomised controlled trial of Psilocybin in treatment resistant depression with the Australian National University Medical School.

Dr Lewis is fascinated by novel therapies and has completed the Certificate in Psychedelic Therapies through Mind Medicine Institute and has a Professional Certificate in Medicinal Cannabis prescribing. In his private practice, Rainbow Mandala Clinic, he treats ADHD, commonly presenting mental disorders and has developed pathways for Ketamine Assisted Psychotherapy in collaboration with psychologists for chronic, difficult to treat psychiatric conditions.

Dr Lewis was a founding Board member of the Australian Multidisciplinary Association for Psychedelic Practitioners holding the Chair of the Educational Subcommittee from May 2023 to June 2024.

If you are not a member but would like to join please head to the website https://amapp.org/apply-for-me... to sign up before registering for the event.

You will be sent a Zoom link on the day of the event.